Morgan Stanley’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-95,530
| Closed | -$985K | – | 8017 |
|
|
2023
Q3 | $985K | Sell |
95,530
-323,728
| -77% | -$3.07M | ﹤0.01% | 4805 |
|
|
2023
Q2 | $3.46M | Buy |
419,258
+390,222
| +1,344% | +$2.34M | ﹤0.01% | 4040 |
|
|
2023
Q1 | $162K | Buy |
29,036
+3,424
| +13% | +$19.6K | ﹤0.01% | 5800 |
|
|
2022
Q4 | $127K | Sell |
25,612
-4,161
| -14% | -$17.1K | ﹤0.01% | 5876 |
|
|
2022
Q3 | $143K | Sell |
29,773
-48,008
| -62% | -$206K | ﹤0.01% | 5897 |
|
|
2022
Q2 | $200K | Sell |
77,781
-35,043
| -31% | -$131K | ﹤0.01% | 5896 |
|
|
2022
Q1 | $649K | Sell |
112,824
-264,054
| -70% | -$2.37M | ﹤0.01% | 5250 |
|
|
2021
Q4 | $5.65M | Buy |
376,878
+116,318
| +45% | +$2.12M | ﹤0.01% | 3590 |
|
|
2021
Q3 | $6.83M | Buy |
260,560
+149,577
| +135% | +$5.51M | ﹤0.01% | 3348 |
|
|
2021
Q2 | $5.55M | Buy |
110,983
+26,049
| +31% | +$1.17M | ﹤0.01% | 3670 |
|
|
2021
Q1 | $3.91M | Sell |
84,934
-7,763
| -8% | -$370K | ﹤0.01% | 3670 |
|
|
2020
Q4 | $3.97M | Buy |
92,697
+13,195
| +17% | +$501K | ﹤0.01% | 3507 |
|
|
2020
Q3 | $3.24M | Sell |
79,502
-37,784
| -32% | -$1.88M | ﹤0.01% | 3166 |
|
|
2020
Q2 | $6.42M | Buy |
117,286
+33,180
| +39% | +$1.9M | ﹤0.01% | 2418 |
|
|
2020
Q1 | $4.4M | Sell |
84,106
-42,487
| -34% | -$2.3M | ﹤0.01% | 2585 |
|
|
2019
Q4 | $6.16M | Buy |
126,593
+29,878
| +31% | +$1.4M | ﹤0.01% | 2959 |
|
|
2019
Q3 | $5.31M | Sell |
96,715
-14,449
| -13% | -$827K | ﹤0.01% | 2815 |
|
|
2019
Q2 | $5.55M | Buy |
111,164
+45,271
| +69% | +$2.25M | ﹤0.01% | 2812 |
|
|
2019
Q1 | $3.72M | Buy |
65,893
+32,184
| +95% | +$1.92M | ﹤0.01% | 3002 |
|
|
2018
Q4 | $2.15M | Sell |
33,709
-16,281
| -33% | -$1.15M | ﹤0.01% | 3708 |
|
|
2018
Q3 | $4.06M | Sell |
49,990
-8,798
| -15% | -$644K | ﹤0.01% | 3395 |
|
|
2018
Q2 | $3.75M | Buy |
58,788
+9,774
| +20% | +$479K | ﹤0.01% | 3485 |
|
|
2018
Q1 | $1.9M | Buy |
49,014
+20,062
| +69% | +$703K | ﹤0.01% | 4052 |
|
|
2017
Q4 | $813K | Buy |
28,952
+11,350
| +64% | +$333K | ﹤0.01% | 4684 |
|
|
2017
Q3 | $471K | Buy |
17,602
+4,980
| +39% | +$95K | ﹤0.01% | 4916 |
|
|
2017
Q2 | $190K | Buy |
12,622
+6,040
| +92% | +$81.5K | ﹤0.01% | 5358 |
|
|
2017
Q1 | $89K | Sell |
6,582
-7,984
| -55% | -$115K | ﹤0.01% | 5644 |
|
|
2016
Q4 | $218K | Buy |
+14,566
| New | +$186K | ﹤0.01% | 5320 |
|
Other funds holding TRHC
Morgan Stanley's TRHC Position: Q4 2023 in Review
Morgan Stanley sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 95,530 shares — an estimated $985K sold.
Morgan Stanley first reported a position in TRHC in Q4 2016 and held it in 28 quarters. The position peaked at $6.83M in Q3 2021. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Morgan Stanley reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Morgan Stanley sold 95,530 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $985K.
- Morgan Stanley first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 28 quarters.
- Morgan Stanley's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $6.83M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.